SUPN icon

Supernus Pharmaceuticals
SUPN

Overview Fund Activity

225 hedge funds and large institutions have $1.67B invested in Supernus Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 74 increasing their positions, 85 reducing their positions, and 27 closing their positions.

Holders
225
Holders Change
+2
Holders Change %
+0.9%
% of All Funds
3.93%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
30
Increased
74
Reduced
85
Closed
27
Calls
$2.43M
Puts
$1.93M
Net Calls
+$500K
Net Calls Change
-$1.92M

Top Buyers

1
Loomis, Sayles & Company
1
Loomis, Sayles & Company
Massachusetts
$49.9M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$38.2M
3
Citadel Advisors
3
Citadel Advisors
Florida
$12.5M
4
CAM
4
Congress Asset Management
Massachusetts
$9.08M
5
Victory Capital Management
5
Victory Capital Management
Texas
$19.7M

Top Sellers

1
LSV Asset Management
1
LSV Asset Management
Illinois
$5.96M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$46.7M
3
ACM
3
Ashford Capital Management
Delaware
$30.8M
4
Two Sigma Investments
4
Two Sigma Investments
New York
$1.19M
5
PP
5
Prudential plc
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
DWP
251
Destiny Wealth Partners
Florida
– – -29 Closed
CFGS
252
Concourse Financial Group Securities
Alabama
– – – –
BCA
253
Berman Capital Advisors
Georgia
$0 22 +8 +57%
7 8 9 10
11